Norflick Eye Drops contain Norfloxacin (0.3%), a broad-spectrum fluoroquinolone antibiotic formulated for ophthalmic use. It helps in treating bacterial conjunctivitis, keratitis, and other ocular bacterial infections, delivering rapid relief from redness, irritation, and discharge.
Norfloxacin works by inhibiting bacterial DNA gyrase, effectively eliminating susceptible pathogens and preventing further infection progression. Its potent antibacterial activity makes it a first-line choice for ophthalmologists in acute and chronic bacterial eye conditions.
The formulation ensures good ocular penetration and patient comfort, supporting frequent dosing protocols for complete bacterial eradication while minimizing risk of recurrence.
From a business standpoint, Norflick Eye Drops fall under the high-demand ophthalmic antibiotic segment, offering consistent prescriptions, repeat sales, and strong profitability for PCD pharma franchise partners. Its trusted efficacy and physician preference make it a profitable portfolio addition for stockists and distributors nationwide.